Scarica l'app Stockscreener
0.9804
0.97%
-0.0096
Dopo l'orario di chiusura:
.98
-0.0004
-0.04%
Precedente Chiudi:
$0.99
Aprire:
$0.99
Volume 24 ore:
59,299
Relative Volume:
0.48
Capitalizzazione di mercato:
$30.76M
Reddito:
$90,000
Utile/perdita netta:
$-33.89M
Rapporto P/E:
-0.9025
EPS:
-1.0863
Flusso di cassa netto:
$-24.68M
1 W Prestazione:
-6.63%
1M Prestazione:
-14.00%
6M Prestazione:
-38.73%
1 anno Prestazione:
-35.50%
Intervallo 1D:
$0.9803
$1.01
Intervallo di 1 settimana:
$0.952
$1.05
Portata 52W:
$0.952
$1.9454
Actinium Pharmaceuticals Inc Stock (ATNM) Company Profile
Nome
Actinium Pharmaceuticals Inc
Settore
Industria
Telefono
646-767-3870
Indirizzo
275 Madison Avenue, 7th Floor, New York, NY
Compare ATNM vs VRTX, REGN, ARGX, ALNY, INSM
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ATNM
Actinium Pharmaceuticals Inc
|
0.9804 | 30.76M | 90,000 | -33.89M | -24.68M | -1.0863 |
VRTX
Vertex Pharmaceuticals Inc
|
438.71 | 111.45B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
761.85 | 80.54B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
746.42 | 46.32B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
318.85 | 42.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
INSM
Insmed Inc
|
162.43 | 35.01B | 606.42M | -1.28B | -997.58M | -6.403 |
Actinium Pharmaceuticals Inc Stock (ATNM) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-08-07 | Downgrade | B. Riley Securities | Buy → Neutral |
| 2024-05-14 | Iniziato | Stephens | Overweight |
| 2023-09-06 | Iniziato | HSBC Securities | Buy |
| 2023-02-21 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2022-09-08 | Iniziato | Cantor Fitzgerald | Overweight |
| 2022-08-25 | Iniziato | B. Riley Securities | Buy |
| 2020-11-05 | Iniziato | Alliance Global Partners | Buy |
| 2017-12-06 | Iniziato | B. Riley FBR, Inc. | Buy |
| 2017-10-23 | Ripresa | ROTH Capital | Buy |
| 2017-09-14 | Iniziato | Maxim Group | Buy |
| 2016-08-25 | Iniziato | ROTH Capital | Buy |
| 2016-02-29 | Iniziato | H.C. Wainwright | Buy |
| 2015-10-15 | Iniziato | FBR Capital | Outperform |
| 2014-10-01 | Iniziato | MLV & Co | Buy |
| 2014-07-22 | Iniziato | Canaccord Genuity | Buy |
Mostra tutto
Actinium Pharmaceuticals Inc Borsa (ATNM) Ultime notizie
Aug Mood: Can Actinium Pharmaceuticals Inc outperform in the next rallyWeekly Market Summary & Detailed Earnings Play Strategies - baoquankhu1.vn
What is HC Wainwright’s Estimate for ATNM FY2026 Earnings? - Defense World
Actinium Pharmaceuticals (NYSE:ATNM) Receives “Overweight” Rating from Stephens - Defense World
ATNM: Stephens & Co. Reiterates Overweight Rating with $5.00 Tar - GuruFocus
Actinium: Q4 Earnings Snapshot - kare11.com
Actinium Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Actinium Pharmaceuticals (NYSE: ATNM) outlines radiotherapy pipeline, losses and 2026 manufacturing plans - Stock Titan
Actinium Pharmaceuticals (ATNM) Eps Diluted (TTM) - Zacks Investment Research
Portfolio Shifts: What is the dividend yield of Actinium Pharmaceuticals Inc2026 Market Overview & Weekly High Return Stock Forecasts - baoquankhu1.vn
ATNM Stock Price, Quote & Chart | ACTINIUM PHARMACEUTICALS INC (NYSEARCA:ATNM) - ChartMill
Actinium Pharmaceuticals (ATNM) board adopts annual Say-on-Pay advisory votes - Stock Titan
Comparing UCB (OTCMKTS:UCBJF) and Actinium Pharmaceuticals (NYSE:ATNM) - Defense World
Fundamentals Check: Is Actinium Pharmaceuticals Inc undervalued by DCF analysis - baoquankhu1.vn
If You Invested $1,000 in Actinium Pharmac (ATNM) - Stock Titan
Stop Loss: What is the next catalyst for Actinium Pharmaceuticals IncCEO Change & Reliable Breakout Forecasts - baoquankhu1.vn
Analysis Recap: Is Actinium Pharmaceuticals Inc stock good for income investors2026 Market Mood & Fast Entry and Exit Trade Plans - baoquankhu1.vn
Wall Street Recap: Is Actinium Pharmaceuticals Inc stock trending bullishInflation Watch & Reliable Intraday Trade Alerts - baoquankhu1.vn
IPO Launch: Can Actinium Pharmaceuticals Inc stock double in the next year2026 Short Interest & High Yield Equity Trading Tips - baoquankhu1.vn
Aug Shorts: What is the dividend yield of Actinium Pharmaceuticals Inc2025 Investor Takeaways & Technical Pattern Alert System - baoquankhu1.vn
Market Rankings: Is Actinium Pharmaceuticals Inc undervalued by DCF analysisJuly 2025 Levels & AI Forecast Swing Trade Picks - baoquankhu1.vn
Why Is Actinium Pharmaceuticals Stock Rising Today? - Stocktwits
Analysis Recap: Can Actinium Pharmaceuticals Inc outperform in the next rallyJuly 2025 Retail & AI Enhanced Execution Alerts - baoquankhu1.vn
ATNM Should I Buy - Intellectia AI
Is now the right time to enter Actinium Pharmaceuticals Inc.Market Activity Recap & AI Based Buy/Sell Signal Reports - mfd.ru
Actinium Pharmaceuticals, Inc. to Present Two Abstracts at the 2026 AACR Annual Meeting - Yahoo Finance
Performance Recap: Can Actinium Pharmaceuticals Inc outperform in the next rallyJuly 2025 Volume & Verified Stock Trade Ideas - baoquankhu1.vn
ATNM PE Ratio & Valuation, Is ATNM Overvalued - Intellectia AI
Actinium Pharmaceuticals Announces CFO Resignation and New Appointment - TradingView
Actinium Pharmaceuticals, Inc. Announces Principal Financial Officer Changes, Effective as of February 27, 2026 - marketscreener.com
Earnings Report: What is the next catalyst for Actinium Pharmaceuticals IncShare Buyback & Safe Capital Growth Stock Tips - baoquankhu1.vn
Earnings Risk: What is the next catalyst for Actinium Pharmaceuticals Inc2025 Performance Recap & Growth Oriented Trade Recommendations - baoquankhu1.vn
Profit Recap: Is Actinium Pharmaceuticals Inc stock trending bullish2025 Trade Ideas & Free Safe Capital Growth Stock Tips - baoquankhu1.vn
US Market Wrap: Is now the right time to enter Actinium Pharmaceuticals IncDip Buying & Reliable Price Breakout Signals - baoquankhu1.vn
Head-To-Head Contrast: Actinium Pharmaceuticals (NYSE:ATNM) versus Avenue Therapeutics (NASDAQ:ATXI) - Defense World
Rally Mode: What is the next catalyst for Actinium Pharmaceuticals IncQuarterly Earnings Report & Smart Allocation Stock Reports - baoquankhu1.vn
What’s the outlook for Actinium Pharmaceuticals Inc.’s sector2025 Market WrapUp & Risk Controlled Swing Alerts - mfd.ru
Contrasting NexImmune (OTCMKTS:NEXI) & Actinium Pharmaceuticals (NYSE:ATNM) - Defense World
Analyzing Leap Therapeutics (NASDAQ:LPTX) and Actinium Pharmaceuticals (NYSE:ATNM) - Defense World
Retail Trends: Should I invest in IGM Biosciences Inc before earningsDay Trade & Reliable Price Breakout Alerts - baoquankhu1.vn
Reviewing Actinium Pharmaceuticals (NYSE:ATNM) & Aadi Bioscience (NASDAQ:AADI) - Defense World
Acute Myeloid Leukemia Market Forecast to 2034: 7MM Opportunity, Strong CAGR, 43,500 Annual Cases, and Pipeline-Driven Growth | DelveInsight - Barchart.com
How Actinium Pharmaceuticals Inc. (7AY1) stock responds to job market shiftsMarket Sentiment Indicators & Free Stay Ahead With Picks - bollywoodhelpline.com
Aug Selloffs: Is Actinium Pharmaceuticals Inc stock trending bullishJuly 2025 Market Mood & Daily Profit Maximizing Trade Tips - baoquankhu1.vn
Actinium Stock Gains Momentum from Clinical Trial Developments - AD HOC NEWS
Short Squeeze: What is the next catalyst for Actinium Pharmaceuticals IncProfit Target & Technical Confirmation Trade Alerts - baoquankhu1.vn
Aug Outlook: Will Actinium Pharmaceuticals Inc. stock outperform value stocks2025 Trade Ideas & Safe Capital Growth Plans - Bộ Nội Vụ
Why is Actinium Pharmaceuticals stock rising today? - MSN
Actinium Pharmaceuticals (NYSE:ATNM) & ProMetic Life Sciences (OTCMKTS:PFSCF) Head to Head Comparison - Defense World
Published on: 2026-01-09 08:22:12 - Улправда
Will Actinium Pharmaceuticals Inc. (Delaware) stock outperform foreign stocksQuarterly Growth Report & Free Weekly Chart Analysis and Trade Guides - ulpravda.ru
Why Actinium Pharmaceuticals Inc. stock remains on buy listsWeekly Stock Analysis & High Accuracy Trade Signal Alerts - Улправда
Actinium Pharmaceuticals Inc Azioni (ATNM) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.49%
1.47%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):